SPAR / CTC0138
SPAR / CTC0138: A randomized, placebo-controlled phase II trial of Simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer
Trial summary:
The primary purpose of this trial is to compare the effect of simvastatin with placebo on the effectiveness and side effects of pre-operative chemoradiotherapy treatment prior to rectal cancer surgery, and on the body’s inflammatory response to cancer.
Receptor status / problem studied:
Inclusion criteria
Exclusion criteria
Open for recruitment
Trial Title
SPAR / CTC0138
Diagnosis
Colorectal cancer
Type of trial
Collaborative
Type of treatement
Radiation Oncology
Phase
II
Locations
Investigators
Principal Investigator